148 related articles for article (PubMed ID: 10395482)
21. GPIIb/IIIa inhibitors: from bench to bedside and back to bench again.
Armstrong PC; Peter K
Thromb Haemost; 2012 May; 107(5):808-14. PubMed ID: 22370973
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic and pharmacodynamic analysis of TS-943, a selective non-peptide platelet glycoprotein-IIb/IIIa (GPIIb/IIIa) receptor antagonist, using a nonlinear mixed effect model in dogs.
Furuya A; Nozawa M; Gotoh J; Jingu S; Akimoto M; Higuchi S; Suwa T; Ogata H
J Pharm Pharmacol; 2002 Jul; 54(7):921-7. PubMed ID: 12162710
[TBL] [Abstract][Full Text] [Related]
23. ME3277, a GPIIb/IIIa antagonist reduces cerebral infarction without enhancing intracranial hemorrhage in photothrombotic occlusion of rabbit middle cerebral artery.
Kawano KI; Fujishima K; Ikeda Y; Kondo K; Umemura K
J Cereb Blood Flow Metab; 2000 Jun; 20(6):988-97. PubMed ID: 10894182
[TBL] [Abstract][Full Text] [Related]
24. Selective alpha IIb beta 3 receptor blockage with peptide TP9201 prevents platelet uptake on Dacron vascular grafts without significant effect on bleeding time.
Mazur C; Tschopp JF; Faliakou EC; Gould KE; Diehl JT; Pierschbacher MD; Connolly RJ
J Lab Clin Med; 1994 Oct; 124(4):589-99. PubMed ID: 7523555
[TBL] [Abstract][Full Text] [Related]
25. Discovery of an orally active series of isoxazoline glycoprotein IIb/IIIa antagonists.
Xue CB; Wityak J; Sielecki TM; Pinto DJ; Batt DG; Cain GA; Sworin M; Rockwell AL; Roderick JJ; Wang S; Orwat MJ; Frietze WE; Bostrom LL; Liu J; Higley CA; Rankin FW; Tobin AE; Emmett G; Lalka GK; Sze JY; Di Meo SV; Mousa SA; Thoolen MJ; Racanelli AL; Olson RE
J Med Chem; 1997 Jun; 40(13):2064-84. PubMed ID: 9207948
[TBL] [Abstract][Full Text] [Related]
26. Platelet glycoprotein IIb/IIIa receptor antagonists derived from isoxazolidines.
Confalone PN; Jin F; Mousa SA
Bioorg Med Chem Lett; 1999 Jan; 9(1):55-8. PubMed ID: 9990456
[TBL] [Abstract][Full Text] [Related]
27. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
[TBL] [Abstract][Full Text] [Related]
28. Prevention of experimental carotid and coronary artery thrombosis by the glycoprotein IIb/IIIa receptor antagonist CRL42796.
Hennan JK; Hong TT; Willens DE; Driscoll EM; Giboulot TA; Lucchesi BR
Br J Pharmacol; 2002 Jul; 136(6):927-37. PubMed ID: 12110617
[TBL] [Abstract][Full Text] [Related]
29. Use of conformationally restricted benzamidines as arginine surrogates in the design of platelet GPIIb-IIIa receptor antagonists.
Sall DJ; Arfsten AE; Bastian JA; Denney ML; Harms CS; McCowan JR; Morin JM; Rose JW; Scarborough RM; Smyth MS; Um SL; Utterback BG; Vasileff RT; Wikel JH; Wyss VL; Jakubowski JA
J Med Chem; 1997 Aug; 40(18):2843-57. PubMed ID: 9288166
[TBL] [Abstract][Full Text] [Related]
30. Design of a new class of orally active fibrinogen receptor antagonists.
Klein SI; Molino BF; Czekaj M; Gardner CJ; Chu V; Brown K; Sabatino RD; Bostwick JS; Kasiewski C; Bentley R; Windisch V; Perrone M; Dunwiddie CT; Leadley RJ
J Med Chem; 1998 Jul; 41(14):2492-502. PubMed ID: 9651154
[TBL] [Abstract][Full Text] [Related]
31. Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy.
Ingall AH; Dixon J; Bailey A; Coombs ME; Cox D; McInally JI; Hunt SF; Kindon ND; Teobald BJ; Willis PA; Humphries RG; Leff P; Clegg JA; Smith JA; Tomlinson W
J Med Chem; 1999 Jan; 42(2):213-20. PubMed ID: 9925726
[TBL] [Abstract][Full Text] [Related]
32. The in vivo pharmacological profile of the novel glycoprotein IIb/IIIa antagonist, SK&F 106760.
Nichols AJ; Vasko JA; Koster PF; Valocik RE; Rhodes GR; Miller-Stein C; Boppana V; Samanen JM
J Pharmacol Exp Ther; 1994 Aug; 270(2):614-21. PubMed ID: 8071853
[TBL] [Abstract][Full Text] [Related]
33. Intravenous antiplatelet efficacy and safety of the platelet GPIIb/IIIa antagonist, DMP 728 in anesthetized dogs.
Mousa SA; Flint S; Lorelli W; Hassell S; Bozarth J; De Grado W; Reilly TM
Thromb Res; 1994 Oct; 76(2):109-19. PubMed ID: 7863463
[TBL] [Abstract][Full Text] [Related]
34. XV454, a novel nonpeptide small-molecule platelet GIIb/IIIa antagonist with comparable platelet alpha(IIb)beta3-binding kinetics to c7E3.
Mousa SA; Forsythe M; Bozarth J; Youssef A; Wityak J; Olson R; Sielecki T
J Cardiovasc Pharmacol; 1998 Nov; 32(5):736-44. PubMed ID: 9821847
[TBL] [Abstract][Full Text] [Related]
35. Novel non-peptide fibrinogen receptor antagonists. 1. Synthesis and glycoprotein IIb-IIIa antagonistic activities of 1,3,4-trisubstituted 2-oxopiperazine derivatives incorporating side-chain functions of the RGDF peptide.
Sugihara H; Fukushi H; Miyawaki T; Imai Y; Terashita Z; Kawamura M; Fujisawa Y; Kita S
J Med Chem; 1998 Feb; 41(4):489-502. PubMed ID: 9484499
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and evaluation of 1,4-benzodioxine derivatives as novel platelet aggregation inhibitors.
Xie Z; Zhao L; Ding X; Kong Y; Li Z
Future Med Chem; 2018 Feb; 10(4):367-378. PubMed ID: 29380625
[TBL] [Abstract][Full Text] [Related]
37. Discovery of an orally active non-peptide fibrinogen receptor antagonist based on the hydantoin scaffold.
Stilz HU; Guba W; Jablonka B; Just M; Klingler O; König W; Wehner V; Zoller G
J Med Chem; 2001 Apr; 44(8):1158-76. PubMed ID: 11312916
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454.
Amirkhosravi A; Mousa SA; Amaya M; Blaydes S; Desai H; Meyer T; Francis JL
Thromb Haemost; 2003 Sep; 90(3):549-54. PubMed ID: 12958625
[TBL] [Abstract][Full Text] [Related]
39. Oral antiplatelet efficacy of the platelet GPIIb/IIIa antagonist, DMP754 in non-human primates.
Mousa SA; Bozarth J; Youssef A; Levine B
Thromb Res; 1998 Mar; 89(5):217-25. PubMed ID: 9645915
[TBL] [Abstract][Full Text] [Related]
40. A monoclonal antibody that recognizes the GPIIb/IIIa antagonist DMP 728. Reversal of the effects of DMP 728 on platelet aggregation and bleeding time in the dog.
Reilly TM; Mousa SA; Racanelli AL; Thoolen MJ; Flint SK; Bozarth JM; Mu DX; Walton HL
Arterioscler Thromb Vasc Biol; 1995 Dec; 15(12):2195-9. PubMed ID: 7489242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
